| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Humanized (from mouse) |
| Target | TACSTD1 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C3455H5371N921O1060S18 |
| Molar mass | 77348.44 g·mol−1 |
 
(what is this?)
(verify) | |
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis. [1] It has undergone preclinical development for the treatment of ovarian cancer and other solid tumors. [2]
- ^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ^ Viventia Biotech Inc.: VB6-845 Archived 2010-03-29 at the Wayback Machine
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Humanized (from mouse) |
| Target | TACSTD1 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C3455H5371N921O1060S18 |
| Molar mass | 77348.44 g·mol−1 |
|
(what is this?)
(verify) | |
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis. [1] It has undergone preclinical development for the treatment of ovarian cancer and other solid tumors. [2]
- ^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ^ Viventia Biotech Inc.: VB6-845 Archived 2010-03-29 at the Wayback Machine
|
| This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
|
| This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |